Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs placebo/open control
All serious adverse events · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in all serious adverse events compared with placebo/open control (high certainty).
1 finding from 1 review
- Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage 2023 · Cochrane Headline outcomes onlyRR 1.02 [0.75, 1.39]4 studies · 2599 participantsHigh